Cargando…

Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence

BACKGROUND AND AIM: The number of longitudinal studies on cognitive functions in patients on buprenorphine-based agonist treatment is limited. Our objective was to assess the change in neurocognitive functions over the first 6 months of buprenorphine-naloxone (BNX) treatment for opioid dependence (O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ghosh, Abhishek, Mahintamani, Tathagata, Rana, Devender K., Basu, Debasish, Mattoo, Surendra K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045353/ https://www.ncbi.nlm.nih.gov/pubmed/35494328 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_792_21

Ejemplares similares

Neurocognitive Functions in Patients with Comorbid Hepatitis C and Opioid Dependence: A Comparative Study
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Sexual dysfunction in men on buprenorphine – naloxone-based substitution therapy
por: Mattoo, Surendra K., et al.
Publicado: (2020)

Opioid substitution therapy with buprenorphine-naloxone during COVID-19 outbreak in India: Sharing our experience and interim standard operating procedure
por: Basu, Debasish, et al.
Publicado: (2020)

The toll of opioid dependence: A research report on the possible role of Toll-like receptor-4 and related immune markers in opioid dependence
por: Mahintamani, Tathagata, et al.
Publicado: (2023)

Course and Correlates of Stigma in Patients on Opioid Agonist Treatment: A Prospective Study from an Outpatient Treatment Program in India
por: Ghosh, Abhishek, et al.
Publicado: (2021)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

The therapeutic relationships, empathy, and satisfaction in teleconsultation for substance use disorders: Better or worse than in-person consultation?
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Telemedicine-assisted stepwise approach of service delivery for substance use disorders in India
por: Ghosh, Abhishek, et al.
Publicado: (2021)

Service users’ perception and attitude toward telemedicine-based treatment for substance use disorders: A qualitative study from India
por: Ghosh, Abhishek, et al.
Publicado: (2023)

Prevalence & correlates of metabolic syndrome in alcohol & opioid dependent inpatients
por: Mattoo, Surendra K., et al.
Publicado: (2011)

Extended lockdown and India’s alcohol policy: a qualitative analysis of newspaper articles
por: Ghosh, Abhishek, et al.
Publicado: (2020)

Utilizing buprenorphine–naloxone to treat illicit and prescription-opioid dependence
por: Mauger, Sofie, et al.
Publicado: (2014)

AGE AT ONSET TYPOLOGY IN OPIOID DEPENDENT MEN: AN EXPLORATORY STUDY
por: De, Biswajit, et al.
Publicado: (2002)

Predictors of retention in the treatment for opioid dependence: A prospective, observational study from India
por: Shouan, Anish, et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

New developments in the management of opioid dependence: focus on sublingual buprenorphine–naloxone
por: Soyka, Michael
Publicado: (2015)

Buprenorphine-based opioid substitution therapy in India: A few observations, thoughts, and opinions
por: Ghosh, Abhishek, et al.
Publicado: (2018)

A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence during Pregnancy: Maternal and Neonatal Outcomes
por: Lund, Ingunn O., et al.
Publicado: (2013)

Relapse Precipitants, Life events and Dysfunction in alcohol and opioid dependent men
por: Mattoo, Surendra K, et al.
Publicado: (2003)

Correlates of Nine-Month Retention following Interim Buprenorphine-Naloxone Treatment in Opioid Dependence: A Pilot Study
por: Håkansson, A., et al.
Publicado: (2016)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Multiple suicide attempts in an individual with opioid dependence: Unintended harm of lockdown during the COVID-19 outbreak?
por: Ghosh, Abhishek, et al.
Publicado: (2020)

Reconsidering the Usefulness of Adding Naloxone to Buprenorphine
por: Blazes, Christopher K., et al.
Publicado: (2020)

Coronavirus disease 2019 pandemic: Ethical concerns for the treatment of individuals with substance use disorders in India
por: Mahintamani, Tathagata, et al.
Publicado: (2020)

Restless Legs Syndrome in Opioid Dependent Patients
por: Ghosh, Abhishek, et al.
Publicado: (2014)

Is Buprenorphine-Naloxone Ready for Prime Time in the Treatment of Opioid Addiction in Managed Care?
por: Curtiss, Frederic R.
Publicado: (2008)

Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
por: Scott, Travis M., et al.
Publicado: (2021)

Oxybutynin treatment for buprenorphine-naloxone-induced hyperhidrosis
por: McCormack, Lindsay, et al.
Publicado: (2021)

Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
por: Martin, Yvette N., et al.
Publicado: (2019)

Family burden in injecting versus noninjecting opioid users
por: Nebhinani, Naresh, et al.
Publicado: (2013)

Serious health threats of novel adulterants of the street heroin: a report from India during the COVID-19 pandemic
por: Mahintamani, Tathagata, et al.
Publicado: (2021)

Pleural Effusion in a Patient with Injection Heroin Use: An Unusual Presentation with an Unusual Pathogen
por: Das, Sauvik, et al.
Publicado: (2020)

Tapentadol, the new kid on the block in India: Is it time to worry?
por: Basu, Debasish, et al.
Publicado: (2020)

Age of onset of dependence: Does it help our understanding of opioid dependence by generating meaningful categories or by acting as a useful dimension? A critical examination of the classic debate in psychiatry
por: Basu, Debasish, et al.
Publicado: (2014)

Relapse rates among veterans on maintenance doses of combination buprenorphine and naloxone for opioid use disorder
por: Binger, Katie J., et al.
Publicado: (2020)

Disparities in Emergency Department Naloxone and Buprenorphine Initiation
por: Papp, Joan, et al.
Publicado: (2023)

Evaluation of the Effectiveness of Buprenorphine-Naloxone on Opioid Overdose and Death among Insured Patients with Opioid Use Disorder in the United States
por: Sun, Tianyu, et al.
Publicado: (2022)

Opioid Drug Utilization and Cost Outcomes Associated With the Use of Buprenorphine-Naloxone in Patients With a History of Prescription Opioid Use
por: Kaur, Aman Deep, et al.
Publicado: (2008)

Multidisciplinary and Integrated Treatment for Substance Use Disorders and Hepatitis C in an Addiction Treatment Service in India
por: Ghosh, Abhishek, et al.
Publicado: (2022)

Neonatal outcomes following in utero exposure to buprenorphine/naloxone or methadone
por: Gawronski, Kristen M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_jgl636vch6s71jq8teqioncjfn